Jeffrey Rein

Jeffrey Rein is a declared insider at 2 companies; the most frequent names are Walgreen Co and MedWorth Acquisition Corp. Over a trading history stretching from 20 December 2005 to 26 June 2013, the count stands at 32 filings.

In open-market terms, that means 1 purchase worth €115k on one side and 7 sales worth €806k on the other. Sales outweigh purchases by €690k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 5 share grants and 7 option exercises. So far in 2013, the count stands at 1 purchase and no sales.

The newest entry dates from 28 June 2013: an open-market purchase of €115k, in MedWorth Acquisition Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.